Due to repayements of liabilities of 0% Regencell Bioscience Holdings Limited improved Leverage Ratio in fourth quarter 2025 to 0.18, a new company high.

Within Legal Cannabis industry Regencell Bioscience Holdings Limited achieved the lowest Leverage Ratio in the fourth quarter 2025. While Leverage Ratio total ranking has deteriorated compared to the third quarter 2025 from to 376 .

Explain Leverage Ratio?
How much Total Liabilitiess RGC´s has?

Select the Comparisons :

None ▼

Select the Ratio:

Leverage Ratio ▼

None ▼

Leverage Ratio ▼

RGC Leverage Ratio	(Jun 30 2025) Q4	0 Q3	0 Q2	0 Q1	(Jun 30 2023) Q4
Y / Y Equity Change	-59.46 %	-59.46 %	-59.46 %	-59.46 %	-29.81 %
Y / Y Total Liabilities Change	51.38 %	51.38 %	51.38 %	51.38 %	-37.97 %
Leverage Ratio MRQ	0.18	0.18	0.18	0.18	0.05
RGC's Total Ranking	# 376	#	#	#	#
Seq. Equity Change	0 %	0 %	0 %	-59.46 %	0 %
Seq. Total Liabilities Change	0 %	0 %	0 %	51.38 %	0 %

New: More RGC's historic Leverage Ratio results >>

Leverage Ratio fourth quarter 2025 Company Ranking
Within:	No.
Legal Cannabis Industry	# 1
Consumer Non Cyclical Sector	# 8
Overall Market	# 376

Leverage Ratio Statistics
High	Average	Low
0.18	0.1	0.05
(Jun 30 2025)		(Jun 30 2023)

Financial Statements
Regencell Bioscience Holdings Limited's Equity	$ 5 Millions	Visit RGC's Balance sheet
Regencell Bioscience Holdings Limited's Total Liabilities	$ 1 Millions	Visit RGC's Balance sheet
Source of RGC's Sales		Visit RGC's Sales by Geography

Cumulative Regencell Bioscience Holdings Limited's Leverage Ratio

RGC's Leverage Ratio for the trailling 12 Months

RGC Leverage Ratio	(Jun 30 2025) 12 Months	0 12 Months	0 12 Months	0 12 Months	(Jun 30 2023) 12 Months
Y / Y Equity TTM Growth	-59.46 %	-49.91 %	-42.04 %	-35.43 %	-29.81 %
Y / Y Total Liabilities TTM Growth	51.38 %	20.15 %	-3.76 %	-22.66 %	-37.97 %
Leverage Ratio TTM	0.18	0.12	0.09	0.07	0.05
Total Ranking TTM	# 1	#	#	#	#
Seq. Equity TTM Growth	-26.83 %	-21.16 %	-17.46 %	-14.87 %	-9.6 %
Seq. Total Liabilities TTM Growth	9.27 %	10.22 %	11.38 %	12.85 %	-13.27 %

Leverage ratio ranking by company, industry and sector >> Back to RGC Financial Strength Comparisons >> Compare RGC Leverage Ratio to its Peers

On the trailing twelve months basis Despite of the repayements of liabilities of 0% in the trailing twelve months ending in Q4 2025, Leverage Ratio improved to 0.18, above Regencell Bioscience Holdings Limited's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Legal Cannabis industry RGC recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has deteriorated during the twelve months ending in the Q4 2025, compared to the prior period, from to 1.

Explain Leverage Ratio?
How much Total Liabilitiess RGC´s has?

TTM Leverage Ratio Company Ranking
Within:	No.
Within the Legal Cannabis Industry	# 0
Consumer Non Cyclical Sector	# 0
Within the Market	# 1

trailing twelve months Leverage Ratio Statistics
High	Average	Low
0.25	0.04	0
0		0

Companies with similar Leverage Ratio in the quarter ending Jun 30 2025, within Legal Cannabis Industry	Leverage Ratio	Jun 30 2025 MRQ Total Liabilities	Jun 30 2025 MRQ Equity
Niagen Bioscience Inc	0.43	$ 27.330 Millions	$ 64.195 Millions
Usana Health Sciences Inc	0.38	$ 203.466 Millions	$ 531.060 Millions
Upexi Inc	0.36	$ 32.564 Millions	$ 90.097 Millions
Tilray Brands Inc	0.33	$ 494.180 Millions	$ 1,489.575 Millions
Mind Medicine mindmed Inc	0.33	$ 60.747 Millions	$ 185.400 Millions
Regencell Bioscience Holdings Limited	0.18	$ 0.895 Millions	$ 4.860 Millions
Cronos Group Inc	0.08	$ 92.115 Millions	$ 1,130.206 Millions

Date modified: 2025-11-01T05:56:14+00:00

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.